Edward (Ted) B. Diskant is a former federal prosecutor and experienced trial lawyer who focuses his practice on representing companies and individuals in a wide range of white collar and regulatory enforcement matters and in complex civil litigation. Ted has extensive experience handling sensitive investigations, with particular expertise in matters involving the anti-bribery laws including the Foreign Corrupt Practices Act (FCPA), wire fraud, healthcare fraud, money laundering, and the Bank Secrecy Act (BSA). Ted also consults on compliance matters and helps clients design, implement and audit compliance programs consistent with US Justice Department (DOJ) and other applicable guidance.
Prior to joining McDermott, Ted spent nine years at the US Attorney’s Office for the Southern District of New York, serving most recently as Chief of the Public Corruption Unit. In that capacity, Ted supervised a team of approximately twenty senior prosecutors, overseeing some of the Office’s most sensitive and high-profile matters, including those involving fraud and financial crimes, the FCPA and the domestic bribery statutes, the campaign finance laws, and the Foreign Agent Registration Act (FARA). Notable matters that Ted supervised include the investigation of attorney to the former president Rudolph Giuliani and the prosecutions of former Giuliani associates Lev Parnas and Igor Fruman, former presidential advisor Stephen K. Bannon, financier Jeffrey Epstein and his former girlfriend Ghislaine Maxwell, and attorney Michael Avenatti.
At the US Attorney’s Office, Ted also served in its Money Laundering and Asset Forfeiture Unit, leading investigations and prosecutions of both corporations and individuals for a wide variety of financial crimes, including violations of the BSA, US sanctions laws, and domestic and international money laundering offenses. Ted also handled significant civil and criminal asset forfeiture matters and spearheaded domestic and international asset recovery efforts. As an Assistant US Attorney, Ted also led investigations focused on healthcare fraud, misbranding and the unlawful distribution of oxycodone and other controlled substances, including matters involving wholesale distributors, pharmacies, and healthcare providers.
An experienced trial and appellate advocate, Ted has successfully tried ten jury trials to verdict and briefed or argued more than a dozen cases before the US Court of Appeals for the Second Circuit.
Prior to joining the US Attorney’s Office, Ted clerked for the Hon. Debra Ann Livingston, Chief Judge, United States Court of Appeals for the Second Circuit, and for the Hon. Sidney H. Stein, United States District Court, Southern District of New York. He was an Articles & Essays Editor for the Yale Law Journal.
Convicted former sportswear company executive, two others after four-week jury trial for charges arising from corruption within the world of NCAA basketball, and successfully briefed and argued the case on appeal. *
Convicted former New York State Senate Majority Leader Dean Skelos of bribery and extortion offenses after a five-week jury trial. *
Oversaw prosecution of Chinese national for FCPA, international money laundering offenses stemming from scheme to offer bribes to foreign officials in Chad and Uganda. *
Oversaw investigation of international corporation for potential FCPA violations arising from efforts to bribe foreign government officials through international travel and hospitality programs.*
Convicted two business owners, after jury trial, of operating a $100 million unlicensed money remitting and internal money laundering scheme through their corporate front. *
Led investigation into international bank’s processing of $1 billion in transactions that violated US sanctions law and related violations of the BSA, resulting in corporate indictment, two-year deferred prosecution agreement. *
Led international efforts to freeze and recoup, through civil forfeiture actions, nearly $100 million obtained through fraud from a Fortune 100 company. *
Convicted owner of pharmaceutical distribution company for $100 million misbranding, healthcare fraud and money laundering scheme *
Convicted pharmacy owners and operators of unlawful oxycodone distribution and money laundering scheme after three-week jury trial. *
Do not send any information or documents that you want to have treated as secret or confidential. Providing information to McDermott via email links on this website or other introductory email communications will not create an attorney-client relationship; will not preclude McDermott from representing any other person or firm in any matter; and will not obligate McDermott to keep confidential the information you provide. McDermott cannot enter into an attorney-client relationship with you until McDermott has determined that doing so will not create a conflict of interest and until you and McDermott have entered into a written agreement or engagement letter that sets forth the terms of our relationship.